Some parts of the portal may cause error messages or display incorrectly due to the transition to a new provider of trading data

YMAB - Y-mAbs Therapeutics, Inc.


IEX Last Trade
13.595
0   0%

Share volume: 0
Last Updated: Fri 20 Dec 2024 09:18:12 PM CET
Research and Development in Biotechnology (except Nanobiotechnology): 0.46%

PREVIOUS CLOSE
CHG
CHG%

$13.60
-5.10
0.60%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Income statement Balance sheet Cash flow To see more then 2 years history Buy Premium
View ratios

Fiscal Date 2022-06-30 2022-09-30 2022-12-31 2023-03-31 2023-06-30 2023-09-30 2023-12-31 2024-03-31
Fiscal Quarter Q2 2022 Q3 2022 Q4 2022 Q1 2023 Q2 2023 Q3 2023 Q4 2023 Q1 2024
Report Date 2022-08-08 2022-11-07 2023-03-30 2023-05-08 2023-08-10 2023-11-13 2024-02-29 2024-05-07
Total revenue 10.797 M 12.537 M 31.447 M 20.251 M 20.751 M 20.454 M 23.363 M 19.931 M
Cost of revenue 1.140 M 2.475 M 2.021 M 2.083 M 4.649 M 2.595 M 2.039 M 2.097 M
Gross profit 9.657 M 10.062 M 29.426 M 18.168 M 16.102 M 17.859 M 21.324 M 17.834 M
    4.19% 192.45% -38.26% -11.37% 10.91% 19.40% -16.37%  
Operating expenses 49.502 M 36.079 M 30.580 M 25.669 M 23.325 M 25.558 M 24.523 M 24.692 M
Selling general and admin 23.082 M 13.626 M 10.793 M 12.251 M 11.270 M 10.200 M 11.135 M 11.425 M
Research and development 26.420 M 22.453 M 19.787 M 13.418 M 12.055 M 15.358 M 13.388 M 13.267 M
Total expenses 50.742 M 38.554 M 32.601 M 27.752 M 27.974 M 28.203 M 26.562 M 26.839 M
    -24.02% -15.44% -14.87% 0.80% 0.82% -5.82% 1.04%  
Operating income -39.945 M -26.017 M -1.154 M -7.501 M -7.223 M -7.749 M -3.199 M -6.908 M
Ebit -39.945 M -26.017 M -1.154 M -7.501 M -7.223 M -7.749 M -3.199 M -6.908 M
Pretax income -41.131 M -27.526 M 1.157 M -6.390 M -6.123 M -7.560 M -793.000 K -6.469 M
    -33.08% -104.20% -652.29% -4.18% 23.47% -89.51% 715.76%  
Income tax 0.000 0.000 0.000 0.000 179.000 K 187.000 K 195.000 K 160.000 K
Net income basic -41.131 M -27.526 M 1.157 M -6.390 M -6.302 M -7.747 M -988.000 K -6.629 M
    33.08% 104.20% -652.29% 1.38% -22.93% 87.25% -570.95%  
Net income -41.131 M -27.526 M 1.157 M -6.390 M -6.302 M -7.747 M -988.000 K -6.629 M
    33.08% 104.20% -652.29% 1.38% -22.93% 87.25% -570.95%